Literature DB >> 16230422

Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans.

Yun-Ling Zheng1, Christopher A Loffredo, Anthony J Alberg, Zhipeng Yu, Raymond T Jones, Donna Perlmutter, Lindsey Enewold, Mark J Krasna, Rex Yung, Peter G Shields, Curtis C Harris.   

Abstract

Cell cycle checkpoints play critical roles in the maintenance of genomic integrity. The inactivation of checkpoint genes by genetic and epigenetic mechanisms is frequent in all cancer types, as a less-efficient cell cycle control can lead to genetic instability and tumorigenesis. In an on-going case-control study consisting of 216 patients with non-small cell lung cancer, 226 population-based controls, and 114 hospital-based controls, we investigated the relationship of gamma-radiation-induced G2-M arrest and lung cancer risk. Peripheral blood lymphocytes were cultured for 90 hours, exposed to 1.0 Gy gamma-radiation, and harvested at 3 hours after gamma-radiation treatment. gamma-Radiation-induced G2-M arrest was measured as the percentage of mitotic cells in untreated cultures minus the percentage of mitotic cells in gamma-radiation-treated cultures from the same subject. The mean percentage of gamma-radiation-induced G2-M arrest was significantly lower in cases than in population controls (1.18 versus 1.44, P < 0.01) and hospital controls (1.18 versus 1.40, P = 0.01). When dichotomized at the 50th percentile value in combined controls (population and hospital controls), a lower level of gamma-radiation-induced G2-M arrest was associated with an increased risk of lung cancer among African Americans after adjusting for baseline mitotic index, age, gender, and pack-years of smoking [adjusted odd ratio (OR), 2.25; 95% confidence interval (95% CI), 0.97-5.20]. A significant trend of an increased risk of lung cancer with a decreased level of G2-M arrest was observed (P(trend) = 0.02) among African Americans, with a lowest-versus-highest quartile adjusted OR of 3.74 (95% CI, 0.98-14.3). This trend was most apparent among African American females (P(trend) < 0.01), with a lowest-versus-highest quartile adjusted OR of 11.75 (95% CI, 1.47-94.04). The results suggest that a less-efficient DNA damage-induced G2-M checkpoint is associated with an increased risk of lung cancer among African Americans. Interestingly, we observed a stronger association of DNA damage-induced G2-M arrest and lung cancer among African Americans when compared with Caucasians. If replicated, these results may provide clues to the exceedingly high lung cancer incidence experienced by African Americans.

Entities:  

Mesh:

Year:  2005        PMID: 16230422      PMCID: PMC1403288          DOI: 10.1158/0008-5472.CAN-05-1003

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.

Authors:  P Kuehl; J Zhang; Y Lin; J Lamba; M Assem; J Schuetz; P B Watkins; A Daly; S A Wrighton; S D Hall; P Maurel; M Relling; C Brimer; K Yasuda; R Venkataramanan; S Strom; K Thummel; M S Boguski; E Schuetz
Journal:  Nat Genet       Date:  2001-04       Impact factor: 38.330

Review 2.  Cell cycle checkpoints and their inactivation in human cancer.

Authors:  M Molinari
Journal:  Cell Prolif       Date:  2000-10       Impact factor: 6.831

3.  Polymorphisms in the DNA repair gene XRCC1 and breast cancer.

Authors:  E J Duell; R C Millikan; G S Pittman; S Winkel; R M Lunn; C K Tse; A Eaton; H W Mohrenweiser; B Newman; D A Bell
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-03       Impact factor: 4.254

4.  Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.

Authors:  D W Bell; J M Varley; T E Szydlo; D H Kang; D C Wahrer; K E Shannon; M Lubratovich; S J Verselis; K J Isselbacher; J F Fraumeni; J M Birch; F P Li; J E Garber; D A Haber
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

Review 5.  Implication of the G2 checkpoint in the maintenance of genome integrity.

Authors:  J Piette; P Muñoz
Journal:  Pathol Biol (Paris)       Date:  2000-04

6.  Cell cycle checkpoints, DNA damage/repair, and lung cancer risk.

Authors:  Xifeng Wu; Jack A Roth; Hua Zhao; Sherry Luo; Yun-Ling Zheng; Silvia Chiang; Margaret R Spitz
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

7.  Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls.

Authors:  Y M Tang; B L Green; G F Chen; P A Thompson; N P Lang; A Shinde; D X Lin; W Tan; B D Lyn-Cook; G J Hammons; F F Kadlubar
Journal:  Pharmacogenetics       Date:  2000-12

Review 8.  Populations and genetic polymorphisms.

Authors:  W W Weber
Journal:  Mol Diagn       Date:  1999-12

9.  DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation.

Authors:  M J Difilippantonio; J Zhu; H T Chen; E Meffre; M C Nussenzweig; E E Max; T Ried; A Nussenzweig
Journal:  Nature       Date:  2000-03-30       Impact factor: 49.962

10.  Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer.

Authors:  E Biros; I Kalina; A Kohút; J Stubna; J Salagovic
Journal:  Lung Cancer       Date:  2001 Feb-Mar       Impact factor: 5.705

View more
  20 in total

1.  Reproductive and hormonal factors and the risk of nonsmall cell lung cancer.

Authors:  Cari L Meinhold; Amy Berrington de González; Elise D Bowman; Alina V Brenner; Raymond T Jones; James V Lacey; Christopher A Loffredo; Donna Perlmutter; Sara J Schonfeld; Glenwood E Trivers; Curtis C Harris
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

2.  Telomere length variation: A potential new telomere biomarker for lung cancer risk.

Authors:  Bing Sun; Ying Wang; Krishna Kota; Yaru Shi; Salaam Motlak; Kepher Makambi; Christopher A Loffredo; Peter G Shields; Qin Yang; Curtis C Harris; Yun-Ling Zheng
Journal:  Lung Cancer       Date:  2015-03-20       Impact factor: 5.705

3.  Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

Authors:  Sharon R Pine; Leah E Mechanic; Lindsey Enewold; Anil K Chaturvedi; Hormuzd A Katki; Yun-Ling Zheng; Elise D Bowman; Eric A Engels; Neil E Caporaso; Curtis C Harris
Journal:  J Natl Cancer Inst       Date:  2011-06-17       Impact factor: 13.506

4.  The radiosensitizing potential of glutaraldehyde on MCF7 breast cancer cells as quantified by means of the G2-chromosomal radiosensitivity assay.

Authors:  Vasiliki I Hatzi; Georgia I Terzoudi; Katarzyna Barszczewska; Vasilios Makropoulos; Gabriel E Pantelias
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

Review 5.  Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale.

Authors:  Tiffany A Wallace; Damali N Martin; Stefan Ambs
Journal:  Carcinogenesis       Date:  2011-04-03       Impact factor: 4.944

6.  Advancing genomic research and reducing health disparities: what can nurse scholars do?

Authors:  Cheedy Jaja; Robert Gibson; Shirley Quarles
Journal:  J Nurs Scholarsh       Date:  2013-03-01       Impact factor: 3.176

7.  Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case-control study.

Authors:  Yun-Ling Zheng; Ourania Kosti; Christopher A Loffredo; Elise Bowman; Leah Mechanic; Donna Perlmutter; Raymond Jones; Peter G Shields; Curtis C Harris
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

8.  Chromosome 9 arm-specific telomere length and breast cancer risk.

Authors:  Yun-Ling Zheng; Christopher A Loffredo; Peter G Shields; Sahar M Selim
Journal:  Carcinogenesis       Date:  2009-06-17       Impact factor: 4.944

9.  Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians.

Authors:  Lindsey Enewold; Leah E Mechanic; Elise D Bowman; Yun-Ling Zheng; Zhipeng Yu; Glenwood Trivers; Anthony J Alberg; Curtis C Harris
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

10.  Associations between history of chronic lung disease and non-small cell lung carcinoma in Maryland: variations by sex and race.

Authors:  Lisa D Gardner; Christopher A Loffredo PhD; Patricia Langenberg; Diane Marie St George; Janaki Deepak; Curtis C Harris; Sania Amr
Journal:  Ann Epidemiol       Date:  2018-05-07       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.